Keyphrases
Adverse Factors
14%
Adverse Prognostic Factor
28%
Biological Behavior
14%
Biotechnology
14%
C-erbB-2
14%
Cell Differentiation
14%
Clinical Behavior
14%
Content Expression
100%
Cooperative Group
14%
Dako
14%
Delayed Diagnosis
28%
DNA Aneuploidy
28%
DNA Content
100%
DNA Ploidy
42%
Epithelial Malignant Tumor
100%
Genetic Aberrations
14%
Hepatoblastoma
100%
Hepatocellular Carcinoma
57%
Histogram
14%
Hyperdiploid
14%
Hypodiploidy
14%
Image Analysis
14%
Image Expression
14%
Immunohistochemistry
14%
In(III)
14%
Kaplan-Meier Method
14%
Liver Tumor
100%
Log-rank Test
14%
Male Patients
14%
Membrane Staining
14%
Metastasis
14%
Neoplastic Cells
14%
Oncogene
14%
Oncogene Expression
100%
Overall Survival
14%
P53 Expression
14%
P53 Overexpression
14%
Pediatric Population
14%
Preoperative Chemotherapy
28%
Primary Malignant
100%
Prognostic Value
14%
Residual Disease
85%
Santa Cruz
14%
Survival Analysis
14%
Survival Curve
14%
Tumor
42%
Tumor Disease
28%
Tumor Protein p53 (TP53)
14%
Univariate Analysis
14%
Unresectable Tumor
14%
Medicine and Dentistry
Aneuploidy
100%
Carcinoma
100%
Cell Differentiation
14%
Cell Oncogene
14%
Diploidy
14%
Hepatoblastoma
100%
Hepatocellular Carcinoma
57%
Image Analysis
14%
Immunohistochemistry
14%
Kaplan Meier Method
14%
Log Rank Test
14%
Metastatic Carcinoma
14%
Minimal Residual Disease
85%
Neoplasm
85%
Oncogene
100%
Oncogene C Erb
14%
Overall Survival
14%
Pediatrics
14%
Ploidy
42%
Preoperative Chemotherapy
28%
Prognostic Factor
28%
Protein P53
42%
Tumor Suppressor Gene
14%
Univariate Analysis
14%
Biochemistry, Genetics and Molecular Biology
Aneuploidy
66%
Cell Oncogene
33%
Cellular Differentiation
33%
Diploidy
33%
DNA Content
100%
Genetics
33%
Oncogene
100%
Oncogene C Erb
33%
Overall Survival
33%
P53
66%
Ploidy
100%
Protein P53
33%
Tumor Suppressor Gene
33%